M9140 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Precemtabart tocentecan

Filter by location:

Encinitas, California1 trial

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

California Cancer Associates for Research & Excellence, Inc.

Phase 1

Santa Monica, California1 trial

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

University of California - Los Angeles - 300208353

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.